HEFFTER BLOG

A New York University research team is using hallucinogenic experiences to help patients come to terms with their mortality.by Roc Morin“‘Some of the things I’m about to say might not make sense,’ began O.M., a 22-year-old cancer survivor. He had the far-off look in his...

At the Psychedelic Science 2013 conference held in Oakland, CA in April 2013, Heffter founder Dave Nichols and Heffter Zurich researcher Franz Vollenweider presented this in-depth workshop focusing on the latest advances in scientific understanding of how psychedelic compounds affect the brain. Dave starts the workshop...

Teri S. Krebs and  Pål-Ørjan JohansenABSTRACTBackgroundThe classical serotonergic psychedelics LSD, psilocybin, mescaline are not known to cause brain damage and are regarded as non-addictive. Clinical studies do not suggest that psychedelics cause long-term mental health problems. Psychedelics have been used in the Americas for thousands...

Once taboo, psychedelics are making an enlightening medical comebackby Jennifer Bleyer / GSAS ’12On a spring day in 2010, “Sandra,” then a 63-year-old ice-skating instructor with short graying hair and an impish smile, received her diagnosis: ovarian cancer, stage 1C. The rock-hard tumor growing inside...